机译:T细胞浸润和适应性Treg抗性,响应于雄激素剥夺或在局部前列腺癌中的疫灭
Columbia Univ Columbia Ctr Translat Immunol Irving Med Ctr New York NY USA;
Columbia Univ Med Ctr Herbert Irving Comprehens Canc Div Hematol &
Oncol New York NY USA;
Johns Hopkins Sidney Kimmel Comprehens Canc Ctr Dept Oncol &
Biostat Baltimore MD USA;
Johns Hopkins Univ Brady Urol Inst Dept Urol Baltimore MD USA;
Northwestern Univ Feinberg Sch Med Dept Urol Chicago IL 60611 USA;
Texas Urol Specialists Dallas TX USA;
Johns Hopkins Univ Brady Urol Inst Dept Urol Baltimore MD USA;
Johns Hopkins Sidney Kimmel Comprehens Canc Ctr Dept Oncol Baltimore MD USA;
Dana Farber Canc Inst Boston MA 02115 USA;
Johns Hopkins Sidney Kimmel Comprehens Canc Ctr Dept Oncol Baltimore MD USA;
Johns Hopkins Sidney Kimmel Comprehens Canc Ctr Dept Oncol Baltimore MD USA;
Johns Hopkins Sidney Kimmel Comprehens Canc Ctr Dept Oncol Baltimore MD USA;
Johns Hopkins Sidney Kimmel Comprehens Canc Ctr Dept Oncol Baltimore MD USA;
Johns Hopkins Univ Sch Med Dept Pathol Baltimore MD 21205 USA;
Johns Hopkins Univ Sch Med Dept Pathol Baltimore MD 21205 USA;
Johns Hopkins Univ Sch Med Dept Pathol Baltimore MD 21205 USA;
Johns Hopkins Univ Sch Med Dept Pathol Baltimore MD 21205 USA;
Johns Hopkins Sidney Kimmel Comprehens Canc Ctr Dept Oncol Baltimore MD USA;
Columbia Univ Columbia Ctr Translat Immunol Irving Med Ctr New York NY USA;
机译:T细胞浸润和适应性Treg抗性,响应于雄激素剥夺或在局部前列腺癌中的疫灭
机译:患者报告的结果通过5年的活跃监测,手术,近距放疗或外部光束辐射,或没有雄激素剥夺治疗局部前列腺癌
机译:第2期随机研究放射治疗和3年雄激素剥夺,在高危局部前列腺癌患者中没有同时的每周多西紫杉醇
机译:日本前列腺癌患者中雄激素剥夺治疗前后的性激素血清水平
机译:T细胞检查点以及PD-1 / L1途径尤其是对DNA疫苗产生抗药性的一种方式,合理的联合疗法可提高疫苗治疗前列腺癌的功效。
机译:HIF1αEGFR和VEGF-A在局部前列腺癌中的表达对接受或不接受雄激素剥夺治疗的中高危患者的预后价值
机译:循环IL-17(+)CD4(+)T细胞(而非Treg)的预处理频率与前列腺癌患者对全细胞疫苗接种的临床反应相关